Outcomes of intratympanic gentamicin injection to treat Ménière's disease.
OBJECTIVE
To investigate the outcomes of intratympanic (IT) gentamicin sulfate injection to treat intractable Ménière's disease (MD) using evidence-based methods.


METHODS
Data were retrieved from a MEDLINE search (January 1995 through January 2011).


METHODS
Selected were English-language articles presenting outcomes of IT gentamicin injection to treat MD that had a prospective study design and an evidence level of II or higher.


METHODS
The database was searched using Boolean combinations of the keywords intratympanic, gentamicin, and Ménière's disease.


RESULTS
Dichotomous outcomes (success rate and total deafness) were expressed using a Mantel-Haenszel fixed-effects model. Pretreatment and posttreatment pure-tone audiometry results, and word discrimination scores were summarized using data synthesis techniques.


CONCLUSIONS
A critical literature appraisal and meta-analysis shows that IT gentamicin injection can control vertigo in patients with MD who have limited hearing injury. The quality of research in this field has improved remarkably over the years. However, a large-scale randomized controlled trial is warranted to confirm the predictive factors for the effectiveness of IT gentamicin injection in treating MD.
Department of Otolaryngology, Cathay General Hospital, New Taipei City, Taiwan, Republic of China.
Leh-Kiong
LK
Huon
Te-Yung
TY
Fang
Pa-Chun
PC
Wang
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005839:Gentamicins / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008575:Meniere Disease / Q000188:drug therapy*; D016896:Treatment Outcome; D014432:Tympanic Membrane
D000900:Anti-Bacterial Agents; D005839:Gentamicins